The new cellular therapies section is accessible through the Haematology and BMT menu on the homepage.
Currently, there are 2 cellular therapy protocols:
ID 3832 B-cell acute lymphoblastic leukaemia tisagenlecleucel and;
ID 3839 Diffuse large B-cell lymphoma tisagenlecleucel.
You can also find relevant clinical resources in our BMT & cellular therapies section.